Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Aug 11, 2017
Clinical News

FDA issues CRL to NDA for Vernalis' CCP-08

BioCentury | Apr 26, 2017
Clinical News

CCP-07 regulatory update

BioCentury | Apr 21, 2017
Company News

Vernalis gets CRL for CCP-07

BioCentury | Sep 12, 2016
Clinical News

CCP-07 regulatory update

BioCentury | Aug 18, 2014
Company News

Tris Pharma, Vernalis Group deal

BioCentury | May 5, 2014
Company News

Tris Pharma, Vernalis deal

Items per page:
1 - 7 of 7